London, United Kingdom
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
20
Total Investments
16
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Arix Bioscience
Recent Investments (20)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Jan 2023 | |
| Post-IPO Equity | •••••• | Aug 2022 | |
| Series A | •••••• | Dec 2021 | |
| Post-IPO Equity | •••••• | Sep 2021 | |
| Series C | •••••• | Jul 2021 | |
•••• ••••
|
Venture Round | •••••• | Mar 2021 |
|
•••• ••••
|
Series B | •••••• | Mar 2021 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Oct 2020 |
|
•••• ••••
|
Series B | •••••• | Jul 2020 |
|
•••• ••••
|
Series C | •••••• | May 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
